NCT03035864View on ClinicalTrials.gov

A 8 Weeks Study to Evaluate Efficacy & Safety of rhNGF vs Vehicle in Patients After Cataract and Refractive Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

January 12, 2017

Primary Completion Date

September 4, 2017

Study Completion Date

September 4, 2017

Conditions

Ocular Discomfort

Interventions

DRUG

rhNGF

Eye Drop 20 μg/mL

OTHER

Vehicle

Vehicle Eye Drop

Trial Locations (1)

Unknown

Univ. G. D'Annunzio-Clinica Oftalmologica-Chieti, Chieti

All Listed Sponsors

lead

Dompé Farmaceutici S.p.A

INDUSTRY

NCT03035864 - A 8 Weeks Study to Evaluate Efficacy & Safety of rhNGF vs Vehicle in Patients After Cataract and Refractive Surgery | Biotech Hunter | Biotech Hunter